A seasoned attorney with more than twenty years of experience addressing complex legal matters arising from government regulation of medical and nutritional products
Washington, DC (July 17, 2017) – Venable LLP announced today that Todd H. Halpern has rejoined the firm as a partner in its FDA practice in Washington, DC, where he will focus on counseling clients on a wide range of matters arising from government regulation of medical and nutritional products. Most recently, Mr. Halpern served as Assistant General Counsel, Regulatory Law, at Pfizer Inc. Before that, he was Of Counsel in Venable's FDA practice group.
"Todd has been recognized for developing creative and practical solutions for businesses facing complex regulatory challenges. Having spent the last decade advising commercial leaders of one of the world's largest manufacturers of pharmaceuticals, biologics, and dietary supplements, Todd understands the challenges that companies in these industries face, and the need to offer advice that not only identifies risk but also furthers business objectives," said Todd A. Harrison, Co-Chair of the firm's FDA practice.
Claudia A. Lewis, who also serves as Co-Chair of the FDA practice, noted, "Todd's knowledge of the regulations governing the development, manufacture, and marketing of consumer products is a great asset. We are especially excited about Todd's expanded experience with good manufacturing practices and DEA-related issues. We are very pleased to have him back on our team."
In his role as Assistant General Counsel with Pfizer, Mr. Halpern served as a regulatory attorney for the company's Manufacturing and Consumer Healthcare Divisions and was a member of the Chief Regulatory Counsel's Leadership Team. He supported litigation, corporate transactions, and a wide range of commercial projects, counseling business leaders and other attorneys on issues relating to regulation by the FDA, FTC, DEA, CPSC, and state regulators. In addition, he managed a team responsible for drafting supply agreements and supporting related litigation.
"Venable is highly regarded for its deep understanding of the regulatory complexities surrounding medical and nutritional products. It is at the forefront of this field and boasts some of the most esteemed legal minds. I am thrilled to reconnect with my colleagues as a member of this very impressive team," said Mr. Halpern.
At Venable, Mr. Halpern joins a practice that operates at the intersection of the FDA and the FTC, an advantage that very few law firms can provide. Many of the firm's attorneys offer decades of marketplace experience and work to assist clients at all stages of the product life cycle – from product development and regulatory approval/clearance to advertising, marketing, and distribution. Venable counsels clients on product formulation, regulatory approval, labeling, good manufacturing practices, claim substantiation, recall issues, and a wide range of matters across all FDA product centers. Venable's successful representation of clients in FDA matters is due to a deep understanding of the statutes and regulations under which the FDA operates.
Mr. Halpern earned his J.D. from Fordham University School of Law and his B.A. from the University of Wisconsin.
Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, and high-net-worth entrepreneurs and individuals. With over 600 attorneys across the country, including California, Delaware, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients' business objectives in the U.S. and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines.